Torsdag 19 Februari | 10:42:46 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-11-03 07:00 Kvartalsrapport 2026-Q3
2026-08-18 07:00 Kvartalsrapport 2026-Q2
2026-06-10 N/A X-dag ordinarie utdelning OSSD 0.00 SEK
2026-06-09 N/A Årsstämma
2026-05-06 07:00 Kvartalsrapport 2026-Q1
2026-02-03 - Bokslutskommuniké 2025
2025-11-04 - Kvartalsrapport 2025-Q3
2025-08-19 - Kvartalsrapport 2025-Q2
2025-06-12 - X-dag ordinarie utdelning OSSD 0.00 SEK
2025-06-11 - Årsstämma
2025-05-06 - Kvartalsrapport 2025-Q1
2025-02-04 - Bokslutskommuniké 2024
2024-12-18 - Extra Bolagsstämma 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-05-22 - X-dag ordinarie utdelning OSSD 0.00 SEK
2024-05-21 - Årsstämma
2024-05-14 - Kvartalsrapport 2024-Q1
2024-02-06 - Bokslutskommuniké 2023
2023-11-21 - Kvartalsrapport 2023-Q3
2023-10-16 - Extra Bolagsstämma 2023
2023-08-22 - Kvartalsrapport 2023-Q2
2023-06-01 - X-dag ordinarie utdelning OSSD 0.00 SEK
2023-05-31 - Årsstämma
2023-05-23 - Kvartalsrapport 2023-Q1
2023-02-21 - Bokslutskommuniké 2022
2022-11-22 - Kvartalsrapport 2022-Q3
2022-08-23 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning OSSD 0.00 SEK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-22 - Bokslutskommuniké 2021
2021-11-17 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-20 - X-dag ordinarie utdelning OSSD 0.00 SEK
2021-05-19 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-04-09 - Extra Bolagsstämma 2021
2021-02-11 - Bokslutskommuniké 2020
2020-11-11 - Kvartalsrapport 2020-Q3
2020-08-19 - Kvartalsrapport 2020-Q2
2020-05-22 - X-dag ordinarie utdelning OSSD 0.00 SEK
2020-05-20 - Årsstämma
2020-05-13 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-19 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
OssDsign är en utvecklare och leverantör av ortobiologiska produkter. Bolaget utvecklar och marknadsför produkter som stödjer kroppens egen läkningsförmåga, exempelvis OssDsign Catalyst, som är ett nanosyntetiskt bentransplantat för dubbla benbildningsvägar genom fusionsmassa. Bolaget erbjuder sina produkter runtom den globala marknaden. OssDsign grundades 2011 och har sitt huvudkontor i Uppsala.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-02-03 07:00:00

Strong growth and real-world data set the stage for U.S. market expansion

OssDsign AB (publ) announces that the year-end report for 2025 is now available as a PDF on the company's website www.ossdsign.com/reports. A PDF version is also attached to this press release. 

The year-end 2025 results will also be presented at an investor webcast today February 3rd at 11:00 CET. The webcast can be accessed via the following link: https://www.finwire.tv/webcast/ossdsign/q4-2025/ or via the OssDsign website.  

 

The fourth quarter in figures

  • Net sales amounted to TSEK 45,123 (41,446), which translates to a growth of 24% compared to the fourth quarter of 2024 at constant exchange rates, or 9% in reported figures. The USD/SEK declined further in the quarter, to a quarter average of 9.42, compared to the 2024 fourth quarter average of 10.76. Underlying quarter-on-quarter growth of 4%.
  • Gross margin of 96.3% (96.8%), an increase compared to the previous quarter's 95.6%, despite negative exchange rate effects, in line with the annual performance.
  • Adjusted EBIT of TSEK -9,411 (-12,261), adjusted for CEO transition costs, was significantly better than the corresponding period in the previous year.
  • Adjusted operating expenses were level with last year and, as expected, higher than the previous quarter, mainly driven by the increase in sales force numbers.
  • EBIT (reported) of TSEK -21,588 (-12,260).
  • Net result for the period amounted to TSEK -22,288 (-13,058).
  • Earnings per share of SEK -0.2 (-0.1).
  • Cash flow from operating activities of TSEK -16,886 (-7,033) was negatively affected by MSEK 8 in one-off payments related to the CEO transition. Adjusted for one-off payments, cash flow from operating activities amounted to MSEK -8.9.

 

The full year in figures

  • Net sales amounted to TSEK 180,159 (133,940), which translates to a strong annual growth of 45% compared to the full year 2024 at constant exchange rates, or 35% in reported figures. The USD/SEK has gone from 11.28 to 9.20 over the course of the year, which translates to an 18.4% decline or MSEK 14.4 off our top line.
  • Gross margin remained high at 96,3% for the full year, compared to 95.4% for 2024.
  • Adjusted EBIT of TSEK -26,499 (-49,425), demonstrated considerable improvement over the previous year. The effects of exchange rate changes at the EBIT level were marginal, with the positive impact on operating expenses offsetting the negative impact on sales and COGS.
  • Adjusted for costs related to LTIP and CEO transition, non-sales variable operating expenses were marginally higher than last year, driven by the increase in sales force numbers. In relative terms, sales commissions and fees were considerably lower than in the previous year.
  • EBIT (reported) of TSEK -46,757 (-49,425).
  • Net result for the period amounted to TSEK -50,988 (-49,656).
  • Earnings per share of SEK -0.5 (-0.5).
  • Cash flow from operating activities of TSEK -64,034 (-62,379). Adjusted for payments related to LTIP and CEO transition, cash flow from operating activities amounted to MSEK -49.0.

 

Significant events during the fourth quarter

  • OssDsign strengthens its commercial footprint in the Western U.S. and delivers growth opportunity through new IDN agreements.
  • OssDsign appoints Mark Waugh as new CEO.

 

Significant events after the end of the fourth quarter

  • There were no significant events after the end of the fourth quarter.

This disclosure contains information that OssDsign AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 03-02-2026 07:00 CET.